NCT07127835 Provocation After Nurse-Directed Assessment (PANDA) Study
| NCT ID | NCT07127835 |
| Status | Recruiting |
| Phase | — |
| Sponsor | The University of Hong Kong |
| Condition | Drug Allergy |
| Study Type | OBSERVATIONAL |
| Enrollment | 440 participants |
| Start Date | 2025-09-01 |
| Primary Completion | 2027-08-31 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 440 participants in total. It began in 2025-09-01 with a primary completion date of 2027-08-31.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The study aims to evaluate the effectiveness and safety of a collaborative nurse-allergist approach in penicillin allergy delabeling services. It also seeks to assess the impact on patients' quality of life and compare resource utilization and cost-effectiveness between the nurse-allergist collaborative approach and the traditional allergist-led approach.
Eligibility Criteria
Inclusion Criteria: * Receiving inpatient or outpatient treatment at a participating hospital during the study period; * Possessing a documented penicillin allergy label; * Underwent penicillin allergy evaluation by the nurse-allergist collaborative approach or the traditional allergist-led approach * Demographic and clinical data required for the study available. Exclusion Criteria: * Patients unable to provide a complete medication history or history of penicillin allergy; * Patients with only emergency or short-term treatment records; * Patients who have taken steroids, antihistamines, or similar medications within the last 3 days.
Contact & Investigator
Frequently Asked Questions
Who can join the NCT07127835 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Drug Allergy. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07127835 currently recruiting?
Yes, NCT07127835 is actively recruiting participants. Contact the research team at le446@hku.hk for enrollment information.
Where is the NCT07127835 trial being conducted?
This trial is being conducted at Hong Kong, Hong Kong, Hong Kong, Hong Kong, Hong Kong, Hong Kong, Hong Kong, Hong Kong.
Who is sponsoring the NCT07127835 clinical trial?
NCT07127835 is sponsored by The University of Hong Kong. The trial plans to enroll 440 participants.